Assistant Professor, Medicine, Perelman School of Medicine
Pulmonology
Dr. Anil Vachani, MD
|
|
Give Review
Anil Vachani, MD practices Pulmonology. He went to medical school at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Anil Vachani is a published doctor and has 52 publications published. The lastest was: 'PILOT AND FEASIBILITY TRIAL OF IMMUNO-GENE THERAPY OF MALIGNANT MESOTHELIOMA USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA COMBINED WITH CHEMOTHERAPY.' Doctor Anil Vachani, MD is registered with Medicare.
Publications
- PILOT AND FEASIBILITY TRIAL OF IMMUNO-GENE THERAPY OF Malignant MESOTHELIOMA USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA COMBINED WITH CHEMOTHERAPY.
- Validation of a multiprotein plasma classifier to identify benign Lung nodules.
- Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.
- Factors That Influence Physician Decision-making for Indeterminate Pulmonary Nodules.
- Development of a genotyping microarray for studying the role of gene-environment interactions in risk for Lung cancer.
- The diagnostic efficacy of combining bronchoscopic tissue biopsy and endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of Malignant le...
- Use of Circulating Tumor Cell Technology (CELLSEARCH®) for the Diagnosis of Malignant Pleural Effusions.
- A blood-based proteomic classifier for the molecular characterization of Pulmonary nodules.
- Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist?
- Determinants of Survival in Advanced Non-Small Cell Lung Cancer in the Era of Targeted Therapies.
- Treatment of tobacco use in Lung cancer: Diagnosis and management of Lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guideli...
- The changing face of outpatient bronchoscopy in 2013.
- Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma.
- The Rac1 splice form Rac1b promotes K-ras-induced Lung tumorigenesis.
- Effect of HIV on survival in patients with non-small-cell Lung cancer in the era of highly active antiretroviral therapy: a population-based study.
- Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the Lung.
- 8-Oxo-2'-Deoxyguanosine as a Biomarker of Tobacco Smoking-Induced Oxidative Stress.
- Peripheral immune cell gene expression predicts survival of patients with non-small cell Lung cancer.
- Natural Variation in the ?-opioid Gene OPRM1 Predicts Increased Pain on Third Day After Thoracotomy.
- Gene therapy for Lung neoplasms.
- Resection of non-small cell Lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.
- A trial of intrapleural adenoviral-mediated Interferon-?2b gene transfer for Malignant pleural mesothelioma.
- Gene therapy for mesothelioma.
- Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women.
- Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.
- Local and systemic recurrence is the Achilles heel of Cancer surgery.
- A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
- Pilot randomized study comparing two techniques of airway anaesthesia during curvilinear probe endobronchial ultrasound bronchoscopy (CP-EBUS).
- HIF-2alpha deletion promotes Kras-driven Lung tumor development.
- Searching for the elusive biomarker in Lung cancer: Where should we look?
- Advances in diagnostic bronchoscopy.
- Gene therapy for mesothelioma and Lung cancer.
- Urinary volatile compounds as biomarkers for Lung cancer: a proof of principle study using odor signatures in mouse models of Lung cancer.
- A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and Metastatic pleural effusions.
- Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell Lung cancer from patients with nonmalignant Lung disease.
- Characterization CSMD1 in a large set of primary Lung, head and neck, breast and skin cancer tissues.
- Kinetics of soluble mesothelin in patients with Malignant pleural mesothelioma during treatment.
- Dietary flaxseed prevents radiation-induced oxidative Lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury.
- A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for Malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor...
- In vitro discrimination of tumor cell lines with an electronic nose.
- A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and Lung squamous cell carcinoma.
- Cytokine gene therapy for Malignant pleural mesothelioma.
- Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute Lung injury in mice.
- Blockade of TNF-alpha decreases both inflammation and efficacy of intraPulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer.
- Cycloxygenase-2 inhibition augments the efficacy of a Cancer vaccine.
- Long-term follow-up of patients with Malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
- IntraPulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung.
- A population-based study of Lung carcinoma in Pennsylvania: comparison of Veterans Administration and civilian populations.
- Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell Lung cancer: a review.
- Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant.
- Local and Systemic thrombolytic therapy for acute venous thromboembolism.
Schools
University Of California San Francisco School Of Medicine
University Pa
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Acidosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
University of California San Francisco School of Medicine
Hospital
-
Philadelphia Veterans Affairs Medical Center -
Hospital of the University of Pennsylvania -
Pennsylvania Hospital -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1861413759 | |
| NPPES Provider LastName | VACHANI | |
| NPPES Provider FirstName | ANIL | |
| NPPES Provider ZIPCode | 191044306 | |
| NPPES Provider State | PA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 474.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861413759 |
| Last Name Of The Provider | VACHANI |
| First Name Of The Provider | ANIL |
| View All |
Similar Doctors
|
|
Dr. Julie John, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Mehmood A. Durrani, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara M. Leighton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia Hsu, MD |
|
|
Dr. Alice M. Goyanes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Bellini, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James C. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven K. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Geller, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren A. Plante, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Misha Peter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Baram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey B. Hoag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell L. Margolis, MD |
|
|
Dr. Daniel H. Sterman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Douglas S. Holsclaw Jr., MD
This Doctor is OpenDoctor Recommended.
|